Mr. Wiley et al., The design of potent, selective, non-covalent, peptide thrombin inhibitorsutilizing imidazole as a S1 binding element, BIOORG MED, 9(18), 1999, pp. 2767-2772
Modeling of neutral or mildly basic functional groups in the S1 site of thr
ombin led to the targeting of imidazole as a S1 binding element and correct
ly predicted the optimal chain length for connecting this group with the S2
and S3 binding elements. Derivatives of 4-(3-aminopropyl)-imidazole can be
selective inhibitors of thrombin demonstrating potent anticoagulant activi
ty. (C) 1999 Elsevier Science Ltd. All rights reserved.